Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

Daihan Pharmaceutical Revenue

Daihan Pharmaceutical had revenue of 51.49B KRW in the quarter ending June 30, 2025, with 5.34% growth. This brings the company's revenue in the last twelve months to 207.68B, up 4.86% year-over-year. In the year 2024, Daihan Pharmaceutical had annual revenue of 204.19B with 4.23% growth.

• Revenue (ttm): 207.68B
• Revenue Growth: +4.86%
• P/S Ratio: 0.85
• Revenue / Employee: 375.55M
• Employees: 553
• Market Cap: 177.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	204.19B	8.28B	4.23%
Dec 31, 2023	195.91B	11.64B	6.32%
Dec 31, 2022	184.27B	12.80B	7.47%
Dec 31, 2021	171.46B	5.38B	3.24%
Dec 31, 2020	166.08B	-2.68B	-1.59%